Gene · 57154
Papers1,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting lysosomal protease CTSL promotes anti-tumor immunity and sensitizes HNSCC to PD-1 blockade by stabilizing PDK1 and activating Akt-PD-L1 axis. | Neoplasia | 2025 | 40961907 | PubTator, text mining | PubMed |
| Gal3-CaN-Smurf1 Complex Sequestrates FLCN-FNIPs to Facilitate TFEB Activation in Response to Endomembrane Damage. | Adv Sci (Weinh) | 2025 | 40958774 | PubTator, text mining | PubMed |
| Selective ubiquitination of drug-like small molecules by the ubiquitin ligase HUWE1. | Nat Commun | 2025 | 40897715 | PubTator, text mining | PubMed |
| Molecular mechanisms of mitochondrial quality control. | Transl Neurodegener | 2025 | 40887660 | PubTator, text mining | PubMed |
| Enriched environment inhibits GLT-1 ubiquitination by downregulating SMURF1 to attenuate ischemic brain injury induced excitotoxicity. | Cell Biosci | 2025 | 40877964 | PubTator, text mining | PubMed |
| Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma. | Cell Death Dis | 2025 | 40855067 | PubTator, text mining | PubMed |
| SSBP1 promotes bovine ephemeral fever virus replication by antagonizing antiviral immune responses via degrading MAVS. | Vet Microbiol | 2025 | 40848354 | PubTator, text mining | PubMed |
| The dual roles of peptidoglycans: NOD1 and NOD2 inversely regulate bone metabolism. | Exp Mol Med | 2025 | 40817410 | PubTator, text mining | PubMed |
| Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma. | iScience | 2025 | 40792032 | PubTator, text mining | PubMed |
| Opposing regulation of the K63-linked polyubiquitination of RIPK3 by SMURF1 and USP5 in necroptosis. | Nat Commun | 2025 | 40783390 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies. | J Hematol Oncol | 2025 | 40750884 | PubTator, text mining | PubMed |
| [Retracted] SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway. | Oncol Rep | 2025 | 40613242 | PubTator, text mining | PubMed |
| BMP6 ubiquitination mediated by SMURF1 suppresses ferroptosis and diminishes sensitivity to doxorubicin in gastric cancer. | Gastroenterol Rep (Oxf) | 2025 | 40584147 | PubTator, text mining | PubMed |
| Toward precision medicine: Inflammatory nasal epithelial transcriptomic profiles in long COVID. | J Allergy Clin Immunol | 2025 | 40482860 | PubTator, text mining | PubMed |
| N-glycosylated LTβR increases the Th17/Treg cell ratio in liver cancer by blocking RORC ubiquitination and FOXP3 transcription. | Cell Death Dis | 2025 | 40436857 | PubTator, text mining | PubMed |
| Regulatory Roles of E3 Ubiquitin Ligases and Deubiquitinases in Bone. | Biomolecules | 2025 | 40427572 | PubTator, text mining | PubMed |
| Spartin Promotes Smurf1-Mediated Ubiquitination Modification of YWHAZ to Inhibit Cisplatin Resistance in Ovarian Cancer. | FASEB J | 2025 | 40386996 | PubTator, text mining | PubMed |
| Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer. | Ann Med | 2025 | 40372974 | PubTator, text mining | PubMed |
| Fortified Withaferin A accelerates the transition from fibrovascular to bone remodeling phase during endochondral bone formation to promote ossification. | Front Endocrinol (Lausanne) | 2025 | 40352455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57154/papers?page=3